The Effect of Once-Weekly 70 Mg Alendronate Versus Once-Daily 10 Mg Alendronate in the Treatment of Postmenopausal Osteoporosis
The aim of this study was to compare the effect of once-weekly 70 mg alendronate versus once-daily 10 mg alendronate in the treatment of postmenopausal osteoporosis. Sixty-three women with postmenopausal osteoporosis were randomly assigned to two groups. The first group consisting of 26 patients rec...
Saved in:
Main Authors: | İlker Çorapçı (Author), Cengiz Öner (Author), Onur Armağan (Author), Yavuz Selim Pehlivan (Author), Funda Taşçıoğlu (Author) |
---|---|
Format: | Book |
Published: |
Galenos Yayinevi,
2004-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effects of Once-Weekly Alendronate 70 mg, Risedronate 35 mg and Raloxifene 60 mg Daily in the Treatment of Postmenopausal Osteoporosis in Turkish Population
by: Mesut Öktem, et al.
Published: (2007) -
The Effect of Alendronate and Calcitonin Treatments on Bone Mineral Density and Quality of Life in Women With Postmenopausal Osteoporosis
by: F. Taşçıoğlu, et al.
Published: (2002) -
Cost-effectiveness of weekly gastro-resistant risedronate 35 mg, compared with weekly alendronate 70 mg tablets, in the treatment of postmenopausal osteoporosis in Spain
by: Enrique Casado, et al.
Published: (2023) -
The Effect of Alendronate and Intranasal Calcitonin Treatments on Bone Mineral Density in Men with Idiopathic Osteoporosis
by: F. Taşçıoğlu, et al.
Published: (2003) -
The Effect of Alendronate in Male Osteoporosis
by: Özlem El, et al.
Published: (2004)